SKYE Skye Bioscience, Inc. - Common Stock
$0,34
Precio · Ago 19, 2026
Fundamentales a fecha de Ago 14, 2026
Rango 52S
$0–$5
1% of range
Calificación del Analista
BUY
13 analysts
Precio Objetivo
$8
+2135% upside
P/E (TTM)
-0.2
ROE
-175.6%
Margen de Beneficio Neto
—
SKYE Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$0.34
Capitalización Bursátil
$11M
P/E (TTM)
-0.2
BPA (TTM)
$-1.41
Ingresos (TTM)
—
Rendimiento div.
—
ROE
-175.6%
Deuda/Capital
—
Rango 52S
$0 – $5
SKYE Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
—
BPA
$-1.41
2018-12-31
→
2025-12-31
Flujo de caja libre
$-43M
2020-12-31
→
2025-12-31
Márgenes
—
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
SKYE
Mediana de Pares
P/E (TTM)
-0.2
—
P/B (P/C)
0.6
1.8
Price / FCF (Precio / FCF)
-0.3
—
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
SKYE
Mediana de Pares
ROA
-110.7%
-72.2%
ROE
-175.6%
-94.1%
ROIC
-290.5%
—
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
SKYE
Mediana de Pares
Current Ratio (Ratio corriente)
3.3
4.0
Quick Ratio (Ratio Rápido)
3.1
—
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
SKYE
Mediana de Pares
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
SKYE
Mediana de Pares
SKYE Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
COMPRA
13 analistas
- Compra fuerte 3 23,1%
- Compra 7 53,8%
- Mantener 3 23,1%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
5 analistas · 2026-08-19
Mediana
$4.00
Media
$7.60
← Por Debajo de Todos los Objetivos
$0.34
Mín
$2.00
Máx
$20.00
Objetivo mediano
$4.00
+1076,1%
Objetivo medio
$7.60
+2134,6%
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-0.48%
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 31 de marzo de 2026 | $-0.32 | $-0.32 | -0.00% |
| 31 de diciembre de 2025 | $-0.36 | $-0.30 | -0.06% |
| 30 de septiembre de 2025 | $-0.32 | $-0.34 | 0.02% |
| 30 de junio de 2025 | $-2.69 | $-0.32 | -2.4% |
| 31 de marzo de 2025 | $-0.28 | $-0.29 | 0.01% |
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| SKYE | $25M | -0.5 | — | — | -175.6% | — |
| CELU | $32M | -0.3 | -51.0% | -345.4% | 288.6% | — |
| CLRB | — | -0.4 | — | — | — | — |
| HOWL | $31M | -0.5 | — | — | -183.6% | — |
| MRKR | $25M | -1.9 | -46.2% | -343.0% | -89.1% | — |
| KALA | $15M | -0.2 | — | — | -1423.8% | — |
| CYCN | — | -1.1 | 3.7% | — | — | — |
| TPST | $14M | -0.5 | — | — | -319.3% | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 15
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | · | · | · | $6M | $3M | $2M | $2M | $330.0K | |
| SG&A Expense | $16M | $18M | $8M | $6M | $5M | $4M | $4M | $4M | |
| Operating Expenses | $58M | $30M | $35M | $18M | $8M | $6M | $7M | $5M | |
| Operating Income | $-58M | $-30M | $-35M | $-18M | $-8M | $-6M | $-7M | $-5M | |
| Interest Expense | $0 | $749.3K | $906.3K | $665.1K | $769.2K | $706.4K | $1M | $94.8K | |
| Interest Income | $2M | $3M | $100.0K | $19.0K | $3 | $29 | $26 | $84 | |
| Other Non-op | $-502 | $-2.2K | $3 | $-1M | $-672.4K | $-270.1K | $8M | $-15M | |
| Pretax Income | $-56M | $-27M | $-38M | $-19M | $-9M | $-7M | $1M | $-19M | |
| Income Tax | $5.4K | $10.1K | $3.6K | $6.7K | $2.1K | $1.6K | $1.6K | $1.6K | |
| Net Income | $-56M | $-27M | $-38M | $-19M | $-9M | $-7M | $1M | $-19M | |
| EPS (Basic) | $-1.41 | $-0.73 | $-5.37 | $-8.77 | $-0.02 | $-0.03 | $0.01 | $-0.16 | |
| EPS (Diluted) | $-1.41 | $-0.73 | $-5.37 | $-8.77 | $-0.02 | $-0.03 | $-0.05 | $-0.16 | |
| Shares (Basic) | 39,662,664 | 36,486,519 | 7,006,038 | 2,221,080 | 406,599,390 | 230,746,878 | 135,154,931 | 121,154,334 | |
| Shares (Diluted) | 39,662,664 | 36,486,519 | 7,006,038 | 2,221,080 | 406,599,390 | 231,420,973 | 169,560,265 | 121,154,334 | |
| EBITDA | $-57M | $-30M | $-35M | $-18M | $-8M | $-6M | $-7M | · |
Balance general 20
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $6M | $68M | $1M | $1M | $9M | $2M | $2M | $2M | |
| Short-term Investments | $20M | $0 | · | · | · | · | · | · | |
| Prepaid Expense | $504.9K | $202.0K | $194.3K | $780.8K | $554.2K | $190.1K | $152.7K | $93.2K | |
| Other Current Assets | $852.0K | $2M | $1M | $481.6K | $56.9K | $275 | $7.5K | $2.6K | |
| Current Assets | $27M | $71M | $12M | $9M | $10M | $3M | $2M | $2M | |
| PP&E (Net) | $898.9K | $1M | $43.3K | $87.9K | $87.7K | $7.3K | $2.0K | $3.4K | |
| PP&E (Gross) | $2M | $2M | $138.7K | · | · | · | · | · | |
| Accum. Depreciation | $773.6K | $233.5K | $95.4K | · | · | · | · | · | |
| Other Non-current Assets | $53.9K | $53.9K | $8.3K | $8.3K | $8.3K | $0 | · | · | |
| Total Assets | $28M | $73M | $12M | $9M | $10M | $3M | $2M | $2M | |
| Accounts Payable | $2M | $569.3K | $1M | $2M | $897.9K | $364.3K | $129.8K | $15.6K | |
| Accrued Liabilities | · | · | · | · | · | $5.5K | $77.9K | · | |
| Current Liabilities | $8M | $4M | $14M | $12M | $4M | $787.2K | $970.8K | $16M | |
| Capital Leases | $84.0K | $273.2K | $171.2K | $0 | $78.7K | $0 | · | · | |
| Total Liabilities | $8M | $5M | $14M | $12M | $4M | $2M | $1M | $18M | |
| Common Stock | $33.4K | $31.0K | $12.3K | $3.7K | $476.1K | $288.1K | $182.9K | $133.9K | |
| Retained Earnings | $-187M | $-131M | $-104M | $-67M | $-47M | $-39M | $-32M | $-33M | |
| Stockholders' Equity | $20M | $68M | $-2M | $-3M | $6M | $450.8K | $548.1K | $-16M | |
| Liabilities + Equity | $28M | $73M | $12M | $9M | $10M | $3M | $2M | $2M | |
| Shares Outstanding | 33,378,139 | 30,974,559 | 12,349,243 | 3,654,119 | 476,108,445 | 288,074,415 | 182,895,247 | 133,907,747 |
Flujo de Efectivo 12
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $723.4K | $298.6K | $124.3K | · | · | · | · | · | |
| Stock-based Comp | $8M | $8M | $987.5K | $629.0K | $869.2K | $302.7K | $680.5K | $675.0K | |
| Other Non-cash | $4M | $-7M | · | · | · | · | · | · | |
| Operating Cash Flow | $-43M | $-25M | $-14M | $-13M | $-6M | $-6M | $-6M | $-4M | |
| CapEx | $6.3K | $2M | $12.6K | $28.1K | $90.9K | $7.2K | · | $4.4K | |
| Investing Cash Flow | $-20M | $-245.6K | $7M | $5M | $-90.9K | $-7.2K | · | $-4.4K | |
| Stock Issued | · | $0 | $5M | $0 | $6M | $6M | $2M | $3M | |
| Net Stock Activity | · | $0 | $5M | $0 | $6M | $6M | $2M | · | |
| Financing Cash Flow | $29.6K | $84M | $16M | $-208.8K | $13M | $7M | $6M | $6M | |
| Net Change in Cash | $-63M | $58M | $9M | $-8M | $7M | $639.5K | $-23.4K | $2M | |
| Free Cash Flow | $-43M | $-27M | $-14M | $-13M | $-7M | $-6M | · | · | |
| Levered FCF | $-43M | $-28M | $-15M | $-13M | $-7M | $-7M | · | · |
Rentabilidad 3
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| ROA | -110.7% | -62.7% | -357.6% | -205.4% | -136.1% | -281.1% | 53.2% | · | |
| ROE | -175.6% | -36.9% | 17246.1% | 619.1% | -120.6% | -569.5% | -13.3% | · | |
| ROIC | -290.5% | -44.3% | 1629.5% | 609.0% | -133.9% | -1395.5% | -1208.4% | · |
Liquidez y Solvencia 3
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.3 | 16.3 | 0.8 | 0.7 | 2.5 | 3.4 | 2.1 | · | |
| Quick Ratio | 3.1 | 15.8 | 0.1 | 0.1 | 2.3 | 3.1 | 1.9 | · | |
| Interest Coverage | · | -40.3 | -38.3 | -27.5 | -10.2 | -8.9 | -6.6 | · |
Valoración (TTM) 8
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-56M | $-27M | $-38M | $-19M | $-9M | $-7M | $1M | $-19M | |
| Market Cap | $25M | $88M | $34M | $3.65B | $6.19B | $2.88B | $5.99B | · | |
| P/E | -0.5 | -3.9 | -0.5 | -0.5 | -650.0 | -333.3 | -655.0 | -625.0 | |
| P/B | 1.3 | 1.3 | -15.8 | -1214.8 | 1055.5 | 6390.5 | 10929.2 | · | |
| P / Tangible Book | 1.3 | 1.3 | · | · | 1055.5 | 6390.5 | · | · | |
| P / Cash Flow | -0.6 | -3.5 | -2.4 | -286.7 | -955.9 | -475.8 | -993.7 | · | |
| P / FCF | -0.6 | -3.3 | -2.4 | -286.1 | -942.7 | -475.3 | · | · | |
| Earnings Yield | -188.0% | -25.8% | -197.4% | -219.2% | -0.15% | -0.30% | -0.15% | -0.16% |
Estado de resultados 15
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | · | · | · | · | · | · | · | · | · | · | · | · | $1M | · | $2M | |
| SG&A Expense | $4M | $5M | $3M | $4M | $4M | $5M | $5M | $5M | $4M | $4M | $2M | $2M | $2M | $2M | $1M | |
| Operating Expenses | $11M | $13M | $15M | $13M | $18M | $12M | $11M | $5M | $8M | $6M | $4M | $25M | $3M | $9M | $3M | |
| Operating Income | $-11M | $-13M | $-15M | $-13M | $-18M | $-12M | $-11M | $-5M | $-8M | $-6M | $-4M | $-25M | $-3M | $-9M | $-3M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $436.9K | $430.1K | $271.3K | $18.4K | $49.6K | $211.2K | |
| Interest Income | $103.2K | $169.6K | $313.3K | $418.5K | $533.1K | $619.1K | $732.3K | $907.7K | $961.2K | $427.6K | $50.3K | $16.6K | $24.5K | $19.0K | $0 | |
| Other Non-op | $0 | $-2.4K | $-41.1K | $0 | $0 | $40.6K | $0 | $-801 | $-359 | $-1.0K | $2M | $0 | $-2M | $-607.0K | $-205.0K | |
| Pretax Income | $-11M | $-13M | $-14M | $-13M | $-18M | $-11M | $-10M | $-4M | $-8M | $-5M | $-4M | $-25M | $-5M | $-10M | $-3M | |
| Income Tax | $3.4K | $0 | $0 | $0 | $3.4K | $2.0K | $0 | $0 | $8.1K | $2.0K | $0 | $0 | $0 | $1.6K | $0 | |
| Net Income | $-11M | $-13M | $-14M | $-13M | $-18M | $-11M | $-10M | $-4M | $-8M | $-5M | $-4M | $-25M | $-5M | $-10M | $-3M | |
| EPS (Basic) | $-0.27 | $-0.32 | $-0.37 | $-0.32 | $-0.44 | $-0.28 | $-0.25 | $-0.10 | $-0.20 | $-0.18 | $-0.03 | $-3.17 | $-1.37 | $-7.17 | $-1.58 | |
| EPS (Diluted) | $-0.27 | $-0.32 | $-0.37 | $-0.32 | $-0.44 | $-0.28 | $-0.25 | $-0.10 | $-0.20 | $-0.18 | $-0.03 | $-3.17 | $-1.37 | $-7.17 | $-1.58 | |
| Shares (Basic) | 39,694,243 | 39,681,465 | -79,314,417 | 39,665,927 | 39,659,266 | 39,651,888 | -69,002,099 | 38,819,387 | 38,669,330 | 27,999,901 | -8,528,284 | 7,880,546 | 3,767,578 | -991,511,177 | 1,983,700 | |
| Shares (Diluted) | 39,694,243 | 39,681,465 | -79,314,417 | 39,665,927 | 39,659,266 | 39,651,888 | -69,002,099 | 38,819,387 | 38,669,330 | 27,999,901 | -8,528,284 | 7,880,546 | 3,767,578 | -991,511,177 | 1,983,700 | |
| EBITDA | $-11M | $-13M | · | $-13M | $-18M | $-12M | · | $-5M | $-8M | $-6M | · | $-25M | $-3M | · | $-3M |
Balance general 21
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $8M | $8M | $6M | $18M | $24M | $46M | $68M | $67M | $74M | $83M | $1M | $5M | $3M | $1M | $415.4K | |
| Short-term Investments | $2M | $9M | $20M | $17M | $25M | $13M | $0 | · | · | · | · | · | · | · | · | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Prepaid Expense | $415.2K | $1M | $504.9K | $4M | $1M | $575.4K | $202.0K | $664.6K | $1M | $640.5K | $194.3K | $207.2K | $957.6K | $780.8K | $708.5K | |
| Other Current Assets | $479.6K | $234.8K | $852.0K | $900.2K | $733.4K | $3M | $2M | $3M | $3M | $2M | $1M | $867.9K | $820.0K | $481.6K | $143.9K | |
| Current Assets | $11M | $19M | $27M | $40M | $51M | $63M | $71M | $80M | $87M | $95M | $12M | $15M | $4M | $9M | $3M | |
| PP&E (Net) | $32.9K | $756.1K | $898.9K | $1M | $1M | $1M | $1M | $2M | $45.8K | $36.1K | $43.3K | $55.3K | $77.1K | $87.9K | $86.2K | |
| PP&E (Gross) | $140.8K | · | $2M | · | · | · | $2M | $2M | · | · | $138.7K | · | · | · | · | |
| Accum. Depreciation | $107.9K | · | $773.6K | · | · | · | $233.5K | $99.6K | · | · | $95.4K | · | · | · | · | |
| Other Non-current Assets | $8.3K | $35.9K | $53.9K | $53.9K | $53.9K | $53.9K | $53.9K | $26.3K | $8.3K | $8.3K | $8.3K | $8.3K | $8.3K | $8.3K | $8.3K | |
| Total Assets | $11M | $19M | $28M | $41M | $52M | $65M | $73M | $82M | $87M | $95M | $12M | $16M | $5M | $9M | $3M | |
| Accounts Payable | $4M | $4M | $2M | $3M | $3M | $2M | $569.3K | $780.0K | $1M | $1M | · | $2M | $1M | · | $2M | |
| Current Liabilities | $12M | $10M | $8M | $8M | $8M | $5M | $4M | $6M | $14M | $16M | $14M | $14M | $9M | $12M | $6M | |
| Capital Leases | $0 | $0 | $84.0K | $120.2K | $172.5K | $223.5K | $273.2K | $108.1K | $129.9K | $151.0K | $171.2K | $190.5K | $0 | $0 | $8.2K | |
| Total Liabilities | $12M | $10M | $8M | $8M | $8M | $6M | $5M | $6M | $14M | $16M | $14M | $14M | $9M | $12M | $6M | |
| Common Stock | $35.1K | $35.1K | $33.4K | $31.0K | $31.0K | $31.0K | $31.0K | $30.3K | $28.1K | $28.1K | $12.3K | $12.3K | $971.5K | $3.7K | $495.9K | |
| Retained Earnings | $-210M | $-199M | $-187M | $-172M | $-160M | $-142M | $-131M | $-121M | $-117M | $-109M | $-104M | $-100M | $-72M | $-67M | $-57M | |
| AOCI | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Stockholders' Equity | $-497.3K | $9M | $20M | $33M | $44M | $59M | $68M | $76M | $73M | $79M | $-2M | $2M | $-5M | $-3M | $-3M | |
| Liabilities + Equity | $11M | $19M | $28M | $41M | $52M | $65M | $73M | $82M | $87M | $95M | $12M | $16M | $5M | $9M | $3M | |
| Shares Outstanding | 35,143,722 | 35,126,884 | 33,378,139 | 30,989,046 | 30,988,108 | 30,974,559 | 30,974,559 | 30,338,290 | 28,067,907 | 28,062,907 | 12,349,243 | 12,338,910 | 971,549,608 | 3,654,119 | 495,925,112 |
Flujo de Efectivo 12
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $157.6K | $172.9K | $180.0K | $178.9K | $187.1K | $177.4K | $175.3K | $47.5K | $29.8K | $27.6K | $86.1K | $12.8K | · | · | · | |
| Stock-based Comp | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $592.9K | $160.2K | $131.6K | $203.2K | $144.1K | |
| Other Non-cash | · | $2M | · | · | · | $-461.4K | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-7M | $-9M | $-10M | $-13M | $-11M | $-9M | $-8M | $-5M | $-7M | $-5M | $-4M | $-4M | $-4M | $-5M | $-2M | |
| CapEx | $0 | $0 | $0 | $0 | $0 | $6.3K | $50.0K | $2M | $32.5K | $3.2K | $7.0K | $3.7K | $1.9K | $12.5K | $10.3K | |
| Investing Cash Flow | $7M | $11M | $-3M | $8M | $-12M | $-13M | $90.4K | $-1M | $-32.5K | $1M | $-7.0K | $1M | $6M | $6M | $-366.1K | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | $-7M | · | · | · | · | |
| Financing Cash Flow | $-101.0K | $-71.5K | $11.4K | $0 | $18.2K | $0 | $5.6K | $0 | $-2M | $86M | $-22.7K | $17M | $-45.3K | $34.2K | $-91.8K | |
| Net Change in Cash | $-80.7K | $2M | $-13M | $-5M | $-23M | $-22M | $-8M | $-7M | $-9M | $82M | $-4M | $14M | $1M | $829.1K | $-3M | |
| Taxes Paid | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Free Cash Flow | · | $-9M | · | · | · | $-9M | · | · | · | $-5M | · | · | $-4M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-5M | · | · | · | · | · |
Rentabilidad 3
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -34.1% | -29.7% | · | -20.8% | -25.3% | -13.9% | · | -8.0% | -17.1% | -10.1% | · | -270.1% | -87.6% | · | -43.0% | |
| ROE | -50.0% | -36.6% | · | -23.5% | -30.3% | -16.1% | · | -10.1% | -21.8% | -13.6% | · | 3138.4% | 571.8% | · | -125.6% | |
| ROIC | 2224.9% | -140.6% | · | -40.4% | -41.8% | -19.9% | · | -6.6% | -11.6% | -7.8% | · | -1457.3% | · | · | 89.0% |
Liquidez y Solvencia 3
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.0 | 1.8 | · | 4.8 | 6.1 | 11.8 | · | 14.2 | 6.1 | 6.0 | · | 1.1 | 0.5 | · | 0.4 | |
| Quick Ratio | 0.9 | 1.6 | · | 4.2 | 5.8 | 11.1 | · | 12.0 | 5.2 | 5.3 | · | 0.4 | 0.3 | · | 0.1 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -14.1 | · | -91.1 | -168.5 | · | -13.8 |
Valoración (TTM) 8
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-54M | $-54M | · | $-45M | $-41M | $-28M | · | $-42M | $-41M | $-38M | · | $-36M | $-15M | · | $-11M | |
| Market Cap | $24M | $22M | · | $122M | $130M | $49M | · | $119M | $225M | $439M | · | $50M | $4.13B | · | $3.22B | |
| P/E | -0.5 | -0.5 | · | -3.4 | -4.1 | -2.1 | · | -1.1 | -1.8 | -2.8 | · | -0.6 | -1.4 | · | -4.1 | |
| P/B | -49.0 | 2.4 | · | 3.7 | 3.0 | 0.8 | · | 1.6 | 3.1 | 5.6 | · | 29.8 | -863.7 | · | -981.3 | |
| P / Tangible Book | · | 2.4 | · | 3.7 | 3.0 | 0.8 | · | 1.6 | 3.1 | 5.6 | · | 29.8 | · | · | · | |
| P / Cash Flow | · | -2.5 | · | · | · | -5.4 | · | · | · | -93.2 | · | · | -1016.8 | · | · | |
| P / FCF | · | -2.5 | · | · | · | -5.4 | · | · | · | -93.2 | · | · | -1016.3 | · | · | |
| Earnings Yield | -194.8% | -221.1% | · | -29.0% | -24.4% | -47.8% | · | -93.3% | -54.3% | -35.3% | · | -169.2% | -69.9% | · | -24.6% |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Beneficio neto | $-56M | $-27M | $-38M | $-19M | $-9M |
| EPS Diluido | $-1.41 | $-0.73 | $-5.37 | $-8.77 | $-0.02 |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio corriente | 3.3 | 16.3 | 0.8 | 0.7 | 2.5 |
| Ratio Rápido | 3.1 | 15.8 | 0.1 | 0.1 | 2.3 |
Flujo de Efectivo
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flujo de caja libre | $-43M | $-27M | $-14M | $-13M | $-7M |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 50 declarantes · $11.3M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 11 (+9 vs trimestre anterior) | 3 (-10 vs trimestre anterior) | 4 (-5 vs trimestre anterior) | 9 (0 vs trimestre anterior) | +1.1M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| 5AM Venture Management, LLC | $6 712 366 | 9 681 763 | 59,24% | Acciones |
| Versant Venture Management, LLC | $1 391 941 | 2 007 704 | 12,28% | Acciones |
| BAKER BROS. ADVISORS LP | $1 092 116 | 1 575 243 | 9,64% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $529 370 | 763 882 | 4,67% | Acciones |
| SPHERA FUNDS MANAGEMENT LTD. | $470 701 | 678 928 | 4,15% | Acciones |
| PLATINUM INVESTMENT MANAGEMENT LTD | $161 605 | 233 095 | 1,43% | Acciones |
| BlackRock, Inc. | $161 449 | 232 870 | 1,42% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $137 637 | 198 524 | 1,21% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $124 295 | 179 201 | 1,10% | Acciones |
| VANGUARD GROUP INC | $78 172 | 104 229 | 0,69% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $72 231 | 104 229 | 0,64% | Acciones |
| Nuveen Asset Management, LLC | $66 191 | 23 389 | 0,58% | Acciones |
| CITADEL ADVISORS LLC | $61 426 | 88 600 | 0,54% | Opción de compra |
| STATE STREET CORP | $51 186 | 73 830 | 0,45% | Acciones |
| NORTHERN TRUST CORP | $39 052 | 56 327 | 0,34% | Acciones |
| UBS Group AG | $37 744 | 54 465 | 0,33% | Acciones |
| TWO SIGMA ADVISERS, LP | $30 724 | 40 982 | 0,27% | Acciones |
| Qube Research & Technologies Ltd | $29 869 | 43 082 | 0,26% | Acciones |
| CITADEL ADVISORS LLC | $24 543 | 35 400 | 0,22% | Opción de venta |
| SIMPLEX TRADING, LLC | $18 702 | 26 976 | 0,17% | Acciones |
| XTX Topco Ltd | $14 554 | 20 993 | 0,13% | Acciones |
| Engineers Gate Manager LP | $14 001 | 20 194 | 0,12% | Acciones |
| GROUP ONE TRADING LLC | $3 182 | 4 589 | 0,03% | Acciones |
| Vanguard Global Advisers, LLC | $3 158 | 4 557 | 0,03% | Acciones |
| MERCER GLOBAL ADVISORS INC /ADV | $2 125 | 3 065 | 0,02% | Acciones |
| MORGAN STANLEY | $1 352 | 1 950 | 0,01% | Acciones |
| BARCLAYS PLC | $455 | 655 | 0,00% | Acciones |
| OSAIC HOLDINGS, INC. | $413 | 600 | 0,00% | Acciones |
| NATIONAL BANK OF CANADA /FI/ | $275 | 400 | 0,00% | Acciones |
| JPMORGAN CHASE & CO | $44 | 66 | 0,00% | Acciones |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $36 | 52 | 0,00% | Acciones |
| TD Waterhouse Canada Inc. | $35 | 52 | 0,00% | Acciones |
| Federation des caisses Desjardins du Quebec | $35 | 51 | 0,00% | Acciones |
| Rockefeller Capital Management L.P. | $27 | 39 | 0,00% | Acciones |
| Optiver Holding B.V. | $14 | 20 | 0,00% | Acciones |
| CoreCap Advisors, LLC | $6 | 8 | 0,00% | Acciones |
| JONES FINANCIAL COMPANIES LLLP | $5 | 8 | 0,00% | Acciones |
| GILPIN WEALTH MANAGEMENT, LLC | $3 | 4 | 0,00% | Acciones |
| Integrated Wealth Concepts LLC | $2 | 2 | 0,00% | Acciones |
| Plante Moran Financial Advisors, LLC | $2 | 3 | 0,00% | Acciones |
| PFS Partners, LLC | $1 | 1 | 0,00% | Acciones |
| HARBOUR INVESTMENTS, INC. | $1 | 1 | 0,00% | Acciones |
| Leo H. Evart, Inc. | $1 | 1 | 0,00% | Acciones |
| TUCKER ASSET MANAGEMENT LLC | $1 | 1 | 0,00% | Acciones |
| WELLS FARGO & COMPANY/MN | $1 | 1 | 0,00% | Acciones |
| NFSG Corp | $1 | 1 | 0,00% | Acciones |
| MCGUIRE CAPITAL ADVISORS INC | $1 | 2 | 0,00% | Acciones |
| FMR LLC | $1 | 1 | 0,00% | Acciones |
| IFP Advisors, Inc | $1 | 1 | 0,00% | Acciones |
| ROYAL BANK OF CANADA | $0 | 120 | 0,00% | Acciones |
Informantes de la empresa 15 insiders · 6 directivos · 10 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Brian Stuart Murphy | CEO, Chief Medical Officer | 20 de octubre de 2015 A | 375 000 | 0 | 0 | $0 |
| John B Hollister | Chief Executive Officer | 4 de diciembre de 2014 A | — | 0 | 0 | $0 |
| Douglas A Cesario | CFO and Secretary | 23 de julio de 2018 A | 643 501 | 0 | 0 | $0 |
| Elizabeth Berecz | Chief Financial Officer | 20 de octubre de 2015 A | 350 000 | 0 | 0 | $0 |
| Cosmas N Lykos | Chairman | 20 de octubre de 2015 A | 3 699 400 | 0 | 0 | $0 |
| Douglas S Ingram | Vice Chairman | 20 de octubre de 2015 A | 372 500 | 0 | 0 | $0 |
| Andrew J. Schwab | Consejero | 31 de enero de 2024 A | 7 943 520 | 0 | 0 | $0 |
| Praveen Tyle | Consejero | 22 de julio de 2021 A | — | 0 | 0 | $0 |
| James L Heppell | Consejero | 10 de octubre de 2018 A | — | 0 | 0 | $0 |
| Avtar S Dhillon | Consejero | 10 de octubre de 2018 A | — | 0 | 0 | $0 |
| Gerald W. Mclaughlin | Consejero | 20 de octubre de 2015 A | 61 250 | 0 | 0 | $0 |
| Thomas George | Consejero | 20 de octubre de 2015 A | 60 000 | 0 | 0 | $0 |
| Emerald Health Sciences Inc. | Propietario del 10% | 1 de febrero de 2019 J | 73 153 917 | 0 | 0 | $0 |
| Reg Alexander Lapham | Propietario del 10% | 13 de marzo de 2017 X | 3 787 500 | 0 | 0 | $0 |
| Punit Dhillon | — | 7 de agosto de 2026 A | 1 419 823 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Activistas y propietarios del %+ 5 8 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| 5AM Co-Investors II, L.P., 5AM Partners II, LLC, 5AM Partners VII, LLC, 5AM Ventures II, L.P., 5AM Ventures VII, L.P., Andrew J. Schwab, John D. Diekman, Kush Parmar, Scott M. Rocklage | 18 de agosto de 2026 | 30,20% | Enmienda | — | SEC |
| 5AM Partners VII, LLC, 5AM Ventures VII, L.P., 5AM Partners II, LLC, 5AM Ventures II, L.P., 5AM Co-Investors II, L.P., Andrew J. Schwab, Kush Parmar, John D. Diekman, Scott M. Rocklage ×2 presentaciones | 16 de diciembre de 2025 | 34,00% | Enmienda | — | SEC |
| 5AM Ventures VII, L.P., 5AM Partners VII, LLC, 5AM Ventures II, L.P., 5AM Co-Investors II, L.P., 5AM Partners II, LLC, Andrew J. Schwab, Kush Parmar, John D. Diekman, Scott M. Rocklage ×3 presentaciones | 13 de marzo de 2024 | — | Presentación inicial | — | SEC |
| Emerald Health Sciences Inc. ×9 presentaciones | 20 de marzo de 2023 | — | Presentación inicial | — | SEC |
| Persona informante no revelada | 28 de marzo de 2017 | — | Presentación inicial | — | SEC |
| Cosmas N. Lykos ×2 presentaciones | 1 de febrero de 2016 | — | Presentación inicial | — | SEC |
| YOSBANI MENDEZ ×2 presentaciones | 12 de noviembre de 2014 | — | Presentación inicial | — | SEC |
| Reg Alexander Lapham | 10 de noviembre de 2014 | — | Presentación inicial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Propiedad de ETFs Mantenido por 2 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.